The Mesothelioma Guide Blog

Using checkpoint inhibitors is the latest hot‑button topic among oncologists and cancer specialists. Mesothelioma is no different. Most use immune checkpoint inhibitors, a form...

With bankruptcy in mind, Johnson & Johnson took another big shot in its fight against mesothelioma claims. According to a report from Bloomberg Law, a California appellate...

Is the internet trustworthy? That’s a loaded question, one without a clear‑cut answer. Zoom in a little closer: Is the internet trustworthy for researching cancer? It’s a...

The top mesothelioma cancer centers in the world offer experienced staff, plenty of treatment options and additional support resources. There’s a subset within the segment of...

The first preference for treating mesothelioma is surgery. If you can remove the cancerous tumors in bulk, quickly, then the chances of a long and healthy life increase...

The U.S. Food and Drug Administration (FDA) granted ONCOFID‑P “orphan drug status” for treating malignant mesothelioma. ONCOFID‑P is a combination of paclitaxel and...

Treatment for peritoneal mesothelioma is today where treatment was three years ago for pleural mesothelioma. Tumor treating fields are not yet acceptable for non-surgical cases....

There are various types of immunotherapy. Could pairing two of them work for malignant mesothelioma? A new study out of the National Cancer Institute is combining an immune...

The next chapter in the Johnson & Johnson asbestos saga is almost written. It might be defined by one word: bankruptcy. According to reports from the Wall Street Journal and...

Immunotherapy and radiation therapy may have a synergistic effect on one another. For people with malignant mesothelioma, this is a source of hope. Two new clinical trials are...